Status:
COMPLETED
Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Lung Non-Small Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment opti...
Detailed Description
PRIMARY OBJECTIVE: I. To develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding options for adjuvant treatment in patients with resected non...
Eligibility Criteria
Inclusion
- PATIENTS:
- Adults \>= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC)
- Appointments to discuss adjuvant treatment of resected NSCLC
- CLINICIANS:
- Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC
- PAG MEMBERS:
- Adults \>= 18 years
- Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)
Exclusion
- PATIENTS
- Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)
Key Trial Info
Start Date :
February 17 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT05416983
Start Date
February 17 2022
End Date
August 31 2023
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905